Conference Description

June 2, 2007
Sheraton Raleigh
421 South Salisbury Street
Raleigh, NC
919-834-9900

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 7.5*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. appreciate that given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statistically significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
2. review early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
3. review glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia
4. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predom inant irritable bowel syndrome and chronic constipation
5. understand the role of immune response modifiers in the treatment of warts; appreciate the mecha - nisms of action and efficacy of anti-inflammatory dose doxycycline in acne Rosacea, and learn appropriate use of topical steroids and calcipo triene for the treatment of psoriasis
6. outline an evidence based approach to the evaluation of insomnia and understand behavioral and pharmacological treatment approaches including their application in the clinical setting
7. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life
8. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical inter - ventions for BPH
9. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, non-traditional, and alternative medical interventions for addressing menopausal symptoms

Agenda:
Saturday, June 2, 2007

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:00		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD
9:00-9:50		Fundamentals of Quality Diabetes Care Patrick J. Boyle, MD
9:50-10:10		Break
10:10-11:00		Insulin Therapy in Type 2 Diabetes – Who, When, and How Patrick J. Boyle, MD
11:00-11:50		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Kenneth Devault, MD
11:50-12:40		Dermatology Therapy Update: Warts, Rosacea and Psoriasis Brian Berman, MD, PhD
12:40-1:30		Lunch
1:30-2:20		Waking up to Insomnia Karl Doghramji, MD
2:20-3:10		Restless Legs Syndrome Karl Doghramji, MD
3:10-3:30		Break
3:30-4:20		Effective Management of BPH by the Primary Care Clinician Louis Kuritzky, MD
4:20-5:10		Hormone Replacement Therapy: Balancing Risks and Benefits Louis Kuritzky, MD
5:10-5:20		Conference Wrap Up and Post Assessment

Faculty:
Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine, Miami, FL

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico
Albuquerque, NM

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
Jacksonville, FL

Karl Doghramji, MD
Professor of Psychiatry, Jefferson Medical College
Director, Sleep Disorders Center
Thomas Jefferson University
Philadelphia, PA

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health
University of Miami School of Medicine
Miami, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainseville, FL

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.5 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 7.5 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 7.5 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.